Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Philips acquires Respironics for $4.9bn in cash

Executive Summary

Royal Philips Electronics NV has agreed to pay $66 cash (a 27% premium) for each of the outstanding shares of Respironics (medical devices for sleep and respiratory disorders), valuing the transaction at $4.9bn, or about four times Respironics's 2007 sales.
Deal Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register